 |
American Head & Neck Society
Translational Research Meeting
April 21-22, 2015
AHNS Annual Meeting
April 22-23, 2015 during the
Combined Otolaryngology Spring Meetings
|
| Tips on Using this Site
Locate an abstract by entering any author's surname into the search box. You may also search by keyword or program ID number.
Broaden your search by typing only a few letters of a keyword; however, do not append the wildcard “*” to a search string.
Type too small? In most browsers, press Control “+” to enlarge type size. Reset by pressing Control “0”.
Results. To view an abstract, click on a title within results. Presenters’ names are underlined among the list of authors.
|
|
|
COSM ABSTRACTS
| S019 |
COMPARISON OF 99MTC-SESTIMIBI AND SPECT/CT IMAGING IN PARATHYROID ADENOMA LOCALIZATION: A COST-EFFECTIVENESS ANALYSIS
Endocrine Surgery
Brittany Barber, MD, Elaine Fung, MD, FRCSC, Daniel O'Connell, MD, MSc, FRCSC, David Cote, MD, MPH, CCFP, FRCSC, Jeffrey Harris, MD, MHA, FRCSC
University of Alberta
|
| S013 |
CLINICAL AND PATHOLOGIC CHARACTERISTICS OF HPV-POSITIVE AND NEGATIVE OROPHARYNGEAL SQUAMOUS CELL CANCER: AN ANALYSIS OF 2,833 CASES
Outcomes
Alexander L Luryi, BS, Benjamin L Judson, MD
Department of Surgery, Yale University School of Medicine, New Haven, CT
|
| S014 |
THE PREOPERATIVE ASSESSMENT AND OVERALL NUTRITION PREDICTS POSTOPERATIVE COMPLICATIONS AND RE-ADMISSIONS IN HEAD AND NECK CANCER PATIENTS
Outcomes
Ashley C Mays, MD, Mitch Worley, BS, Feras Ackall, BS, Joshua Waltonen, MD, Ralph D'Agostino, Jr., PhD
Wake Forest Baptist Health
|
| S015 |
WHAT PREDICTS TRIPLE MODALITY THERAPY FOR PATIENTS WITH T1 AND T2 OROPHARYNGEAL TUMORS UNDERGOING PRIMARY SURGICAL TREATMENT?
Outcomes
Benjamin R Roman, MD, MSHP1, Snehal G Patel, MD1, Jatin P Shah, MD1, Marc A Cohen, MD2
1Memorial Sloan Kettering Cancer Center, 2Weill Cornell Medical College
|
| S016 |
ACCURACY & PREDICTIVE VALUE OF THYROID NODULE FNA: THE NEED FOR INSTITUTIONAL INTROSPECTION
Endocrine Surgery
Marcus J Magister, BS, Irina Chaikhoutdinov, MD, Brian Saunders, MD, David Goldenberg, MD
Penn State Hershey Medical Center
|
| S017 |
IS THE COST OF SURVEILLANCE JUSTIFIABLE IN PATIENTS WITH LOW-RISK DIFFERENTIATED THYROID CANCER?
Endocrine Surgery
Laura Y Wang, MBBS, MS, Benjamin R Roman, MD, MSHP, Jocelyn C Migliacci, MA, Michael R Tuttle, MD, Ashok R Shaha, MD, Jatin P Shah, MD, Snehal G Patel, MD, Ian Ganly, MD, PhD
Memorial Sloan Kettering Cancer Center
|
| S018 |
COST EFFECTIVENESS OF INTRAOPERATIVE PATHOLOGY IN THE MANAGEMENT OF INDETERMINATE THYROID NODULES
Endocrine Surgery
Christopher Vuong, MD, Daniel Kwon, MD, Alfred Simental, MD, Cherine Kim, Sonia Mohan, MD, Pedro Andrade Filho, MD, Mia Perez, MD, Steve Lee, MD, PhD
Loma Linda University Medical Center
|
| S020 |
SURGICAL CONSIDERATION AND THE ASSOCIATION BETWEEN TUMOR SIZE AND MICROSCOPIC EXTRATHYROIDAL EXTENSION IN DIFFERENTIATED THYROID CANCER
Endocrine Surgery
Manish A Shaha, BS, Laura Y Wang, MBBS, MS, Jennifer Cracchiolo, Jatin P Shah, MD, Snehal G Patel, MD, Ian Ganly, MD, PhD, R. Michael Tuttle, MD, Ashok R Shaha, MD
Memorial Sloan Kettering Cancer Center
|
| S008 |
PRELIMINARY RESULTS OF A PHASE II RANDOMIZED TRIAL OF DCA (DICHLOROACETATE) IN COMBINATION WITH CISPLATIN AND DEFINITIVE RADIATION IN STAGE III-IV SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Experimental Therapeutics/Molecular Targets
Steven F Powell, MD, William C Spanos, MD, Andrew Terrell, MD, Miroslaw Mazurczak, MD, Michael Keppen, MD, Sana Jeffreys, MD, Elie Dib, MD, Mark Gitau, MD, Keely Hack, MD, Steven McGraw, MD, Michelle Lohr, MD, Ashley Jensen, Susan Puumala, PhD, Keith Miskimins, PhD, Lora Black, RN, Kimberly Lee, BS, John Lee, MD
Sanford Health
|
| S001 |
SOCIODEMOGRAPHIC DISPARITIES IN CHOICE OF THERAPY AND SURVIVAL IN ADVANCED STAGE LARYNGEAL CANCER
Decisions in Advanced Head and Neck Cancer
Alok T Saini, MD, Eric Genden, MD, MBA, Uchechukwu Megwalu, MD, MPH
Mount Sinai Hospital
|
|